Status:
COMPLETED
Gel-200 Extension and Open-Label Study in Osteoarthritis of the Knee
Lead Sponsor:
Seikagaku Corporation
Conditions:
Osteoarthritis of the Knee
Eligibility:
All Genders
40-80 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine if a single or repeat intra-articular injection of Gel-200 is safe and effective in subjects with symptomatic osteoarthritis of the knee and to determine if o...
Eligibility Criteria
Inclusion
- Previous participation in study SI-6606/01.
Exclusion
- Female subjects who are pregnant or lactating.
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
202 Patients enrolled
Trial Details
Trial ID
NCT00450112
Start Date
March 1 2007
End Date
June 1 2009
Last Update
August 22 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SKK
Plantation, Florida, United States, 33324